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Abstract
 
Tec family kinases are implicated in T cell receptor (TCR) signaling, and combined mutation
of inducible T cell kinase (Itk) and resting lymphocyte kinase (Rlk)/Txk in mice dramatically
impairs mature T cell function. Nonetheless, mutation of these kinases still permits T cell de-
 
velopment. While 
 
itk
 
2
 
/
 
2
 
 mice exhibit mild reductions in T cells with decreased CD4/CD8 cell
ratios, 
 
rlk
 
2
 
/
 
2
 
itk
 
2
 
/
 
2
 
 mice have improved total T cell numbers yet maintain decreased CD4/CD8
ratios. Using TCR transgenics and an in vitro thymocyte deletion model, we demonstrate that
mutation of Tec kinases causes graded defects in thymocyte selection, leading to a switch from
negative to positive selection in 
 
rlk
 
2
 
/
 
2
 
itk
 
2
 
/
 
2
 
 animals. The reduction in both positive and nega-
tive selection and decreased CD4/CD8 ratios correlates with decreased biochemical parameters
 
of TCR signaling, specifically defects in capacitive Ca
 
2
 
1
 
 influx and activation of the mitogen-
activated kinases extracellular signal–regulated kinase 1 and 2. Thus, Tec kinases influence cell
fate determination by modulating TCR signaling, leading to altered thresholds for thymocyte
selection. These results provide support for a quantitative model for thymic development and
provide evidence that defects in negative selection can substantially alter thymic cellularity.
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Introduction
 
Development of a proper immune system requires the se-
lection of lymphocytes expressing a useful repertoire of an-
tigen receptors that can respond to foreign or dangerous
antigens but not to self. For T cells developing in the thy-
mus, these selection processes include both positive and
 
negative selection of immature CD4
 
1
 
CD8
 
1
 
 cells, helping
shape the mature T cell repertoire. These processes are
thought to be regulated in large part through the interac-
tions between the TCR expressed on a given thymocyte
and peptides presented in the context of either class I or II
MHC molecules (for review see reference 1).
Several models have been put forth to account for how
these distinct selection processes result from signals from
the same receptor (for review see reference 1). One model
suggests that the strength of the signal generated through
the TCR in developing thymocytes affects the develop-
ment of the T cell repertoire. Strong signals that result
from high affinity or avidity interactions between the
TCR and MHC plus peptide lead to negative selection
and death, presumably because these types of signals arise
from self-antigens present in the thymus. Intermediate or
weak signals from the TCR result in survival and matura-
tion (positive selection) of cells that will expand and popu-
late the periphery. Thus, signals that fail to effectively acti-
 
vate peripheral cells can promote development of thymocytes.
Absent or minimal signals, such as when cells express a
TCR that does not interact with the appropriate MHC,
lead to death by neglect.
Alternatively, other models suggest that specific mole-
cules influence selection choices (1). According to this
view, qualitative differences in signaling could account for
choices between positive and negative selection processes.
For example, expression of dominant-negative mitogen-
 
activated protein (MAP)
 
1
 
 and extracellular signal–regulated
kinase (ERK) kinase (MEKK) or Ras mutants alter positive
 
Address correspondence to Pamela L. Schwartzberg, Bldg. 49/4A38, 49
Convent Dr., National Human Genome Research Institute, NIH, Be-
 
thesda, MD 20892-4472. Phone: 301-435-1906; Fax: 301-402-2170;
E-mail: pams@nhgri.nih.gov
 
1
 
Abbreviations used in this paper:
 
 DP, double-positive; ERK, extracellular
signal–regulated kinase; GRB, growth factor receptor–bound protein;
HSA, human serum albumin; LAT, linker of activated T cells; MAP, mi-
togen-activated protein; PI, propidium iodide; PLC, phospholipase C; SP,
single-positive; WT, wild-type; XLA, X-linked agammaglobulinemia.
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but not negative selection, suggesting that activation of
specific downstream molecules may contribute to selection
decisions in the thymus (2, 3). However, as different mole-
cules downstream of the TCR may be activated by differ-
ent thresholds of signaling, the two above models may not
be mutually exclusive.
The Tec kinases comprise the second largest family of
nonreceptor tyrosine kinases with several members ex-
pressed specifically in cells of the hematopoietic lineages
(4). Mutations of the Tec family kinase Bruton’s tyrosine
kinase (Btk) are associated with a profound B cell immuno-
deficiency, X-linked agammaglobulinemia (XLA), with
defective B cell development and Ig secretion resulting
from impaired signaling from surface IgM (5, 6). In T cells,
at least three Tec kinases are expressed: Tec, a widely ex-
pressed kinase, and resting lymphocyte kinase (Rlk)/Txk
and inducible T cell kinase (Itk), which have expression
primarily restricted to the T cell lineage and mast cells. De-
spite the profound B cell developmental block observed in
patients with XLA and a milder block in B cell develop-
ment in the corresponding mutant 
 
xid
 
 mice, mice with
mutations of Rlk/Txk or Itk still develop near normal
numbers of T cells (7, 8). In 
 
rlk
 
2
 
/
 
2
 
 mice, T cell numbers
and patterns are similar to wild-type (WT) mice (7). Tar-
geted disruption of 
 
itk
 
 leads to only mild reductions in T
cell numbers, preferentially affecting the CD4 subset, so
that a decreased CD4/CD8 ratio is observed (7, 8).
To address the function and possible redundancy of Tec
family kinases in T cells, we generated double knockouts of
Rlk/Txk and Itk. These mice still develop mature T cells,
but when compared with cells from either 
 
rlk
 
2
 
/
 
2
 
 or 
 
itk
 
2
 
/
 
2
 
mice, 
 
rlk
 
2
 
/
 
2
 
itk
 
2
 
/
 
2
 
 T cells respond very poorly to TCR
stimulation (7). Despite more severe defects in TCR-induced
proliferation and cytokine production, 
 
rlk
 
2
 
/
 
2
 
itk
 
2
 
/
 
2
 
 mice
have increased mature T cell numbers compared with Itk-
deficient mice. Nonetheless, they maintain a decreased
CD4/CD8 cell ratio, suggesting that 
 
rlk
 
2
 
/
 
2
 
itk
 
2
 
/
 
2
 
 
 
thy-
mocytes may undergo altered developmental processes.
To examine T cell development in mice deficient in Tec
family kinases, we have evaluated thymic development us-
ing TCR-transgenic mice and an in vitro model of dele-
tion. We demonstrate here that mutation of these Tec fam-
ily kinases alters both positive and negative selection. The
reduction in both positive and negative selection and the
decreased CD4/CD8 ratio correlate with decreased bio-
chemical parameters of TCR signaling, including defects in
capacitive Ca
 
2
 
1
 
 influx and ERK activation. Our results
suggest that alterations in TCR signaling resulting from
mutation of Tec kinases may change both thymic selection
and lineage commitment by altering thresholds for selec-
tion and implicate Tec kinases as key modulators of TCR
signaling required for normal thymic development.
 
Materials and Methods
 
Mice. rlk
 
2
 
/
 
2
 
, 
 
itk
 
2
 
/
 
2
 
, and 
 
rlk
 
2
 
/
 
2
 
itk
 
2
 
/
 
2
 
 mice were previously
described. 
 
itk
 
2
 
/
 
2
 
 mice were a gift from Dr. D. Littman (New
York University, New York, NY). Mice used in this study had
 
been backcrossed to C57Bl6/J for four generations and were
maintained in sterile isolator cages on autoclaved food and water.
HY and AND transgenic mice on a C57Bl/6 (H-2
 
b
 
) background
were a gift of Dr. B.J. Fowlkes (National Institute of Allergy and
Infectious Diseases, Bethesda, MD). 
 
rlk
 
2
 
/
 
2
 
itk
 
2
 
/
 
2
 
 
 
mice were in-
terbred with TCR-transgenic mice, and the F1 progeny were in-
terbred to generate transgene-positive mice in the control, 
 
rlk
 
2
 
/
 
2
 
,
 
itk
 
2
 
/
 
2
 
, and 
 
rlk
 
2
 
/
 
2
 
itk
 
2
 
/
 
2
 
 backgrounds.
 
Antibodies and Reagents.
 
Antibodies for flow cytometry were
obtained from PharMingen unless otherwise noted. The follow-
ing reagents were gifts from the people noted in parentheses:
FITC-conjugated T3.70 directed against the HY clonotypic
TCR (Dr. E.W. Shores, Food and Drug Administration, Be-
thesda, MD); anti-CD28 ascites (Drs. J. Powell and R. Schwartz,
National Institute of Allergy and Infectious Diseases, Bethesda,
MD); anti-CD8
 
a
 
 (83-12-5; Dr. A. Singer, National Cancer In-
stitute, Bethesda, MD); growth factor receptor–bound protein
(GRB)-2–glutathione-
 
S
 
-transferase (GST) protein fusion con-
structs (Dr. R. Wange, National Institute of Aging, Baltimore,
MD); anti–Zap-70 and TCR-
 
z
 
 antibodies (Dr. L. Samelson, Na-
tional Cancer Institute, Bethesda, MD); and HY peptide (Dr. M.
Vacchio, National Cancer Institute, Bethesda, MD). Antibodies
directed against Vav, Cbl, and ERK 1 and 2 were obtained from
Santa Cruz Biotechnology, Inc., antiactive ERK antibodies were
from Promega and Santa Cruz Biotechnology, Inc., antiphospho-
tyrosine (4G10) and anti–phospholipase C (PLC)-
 
g
 
1 (mixed
monoclonal) were from Upstate Biotechnology, and anti–phos-
pho-p38 was from New England Biolabs, Inc.
 
Flow Cytometry.
 
Individual cells were prepared from thymi
and stained and analyzed by flow cytometry on a FACScan™
(Becton Dickinson) as previously described (7).
 
Proliferation Assays.
 
Single-cell suspensions were prepared
from spleens of HY-transgenic mice. Red blood cells were lysed
in ammonium chloride and then resuspended at 10
 
6
 
 per milliliter
in the presence of varying numbers of WT irradiated splenocytes
incubated with 10 
 
m
 
M HY peptide (KCSRNRGYL). 48 h later,
cells were pulsed with [
 
3
 
H]thymidine and harvested after 8 h.
 
Cell Death Assays.
 
Individual thymocyte suspensions were
plated at 10
 
6
 
 in 1 ml of RPMI plus 10% FCS, with 2 mM
glutamine, penicillin/streptomycin, and 2-ME on 24-well plates
coated with either 10 
 
m
 
g/ml 2C11 and 10 
 
m
 
g/ml hamster IgG,
10 
 
m
 
g/ml anti-CD28, and 10 
 
m
 
g/ml hamster IgG or both 10 
 
m
 
g/
ml 2C11 and anti-CD28. Alternatively anti-CD28 ascites were
used at a 1:500 dilution. Control plates were coated with hamster
IgG at 10 
 
m
 
g/ml. Cells were incubated at 37
 
8
 
C in 5% CO
 
2
 
 for
18–24 h and then harvested, stained with anti-CD4 and CD8,
and analyzed in the presence of 50 
 
m
 
g/ml propidium iodide (PI).
Live cells were collected for a constant time. In other experi-
ments, CD4
 
1
 
CD8
 
1
 
 double-positive (DP) cells were enriched by
panning twice on anti-CD8–coated plates. After panning, cells
were 90–95% DP CD4
 
1
 
CD8
 
1
 
 cells. 2 
 
3 
 
10
 
6
 
 cells were incu-
bated in 500 
 
m
 
l on a 24-well plate coated with antibodies as
above, harvested 16–24 h later, stained with anti-CD4, CD8,
TCR-
 
b
 
, and PI at 66 ng per 10
 
6
 
 cells, and washed one time be-
fore analysis. In these experiments, absolute numbers of live cells
recovered were calculated based on the number of live cells (ex-
cluding trypan blue) and flow cytometry profiles.
 
Immunoprecipitation and Western Blotting.
 
Individual cell prep-
arations were resuspended in serum-free media and stimulated on
plates coated with 3 
 
m
 
g/ml 2C11 for varying times. Alternatively,
cells were incubated with biotinylated 2C11 and streptavidin
(Sigma-Aldrich) and lysed after indicated times. Cells were either
lysed in 2
 
3
 
 protein sample buffer (2% SDS, 0.1 M Tris, pH 6.8,
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20% glycerol) for examination of total tyrosine phosphorylation
or alternatively in an equal volume of 1% SDS, and then diluted
10-fold with 1% Triton X-100 in PBS with protease inhibitors
(Roche Molecular Biochemicals) and sodium orthovanadate for
immunoprecipitations. Lysates were clarified by centrifugation
and then incubated with the appropriate antibodies for 3–12 h.
Protein A–Sepharose or antimouse Sepharose beads were added
for 1 h and then collected by centrifugation. Beads were washed
three times in 0.5% Triton X-100 in PBS containing protease in-
hibitors and sodium orthovanadate and then resuspended in pro-
tein sample buffer and separated on 10% Tris–glycine gels, trans-
ferred to nitrocellulose, and immunoblotted with appropriate
antibodies. For affinity precipitations, 25 
 
m
 
l of glutathione beads
bound to GRB-2–GST fusion protein were incubated with cell
lysates for 2–4 h and then washed and analyzed as above.
 
Ca
 
2
 
1
 
 Mobilization.
 
Individual cells were isolated and then la-
beled with Fluo-3 AM and Fura-Red AM (Molecular Probes) for
30 min. Cells were washed and held in the dark and then resus-
pended in PBS with Ca
 
2
 
1
 
 either in the absence or presence of 2
mM EGTA. Baseline Ca
 
2
 
1
 
 measurements were recorded, and
then cells were stimulated with either biotinylated 2C11 followed
by streptavidin or by thapsigargan. Measurements were recorded
for at least 10 min and analyzed with Multitime Software
(Pheonix Flow Systems).
 
Results
 
Altered Thymocyte Populations in itk
 
2
 
/
 
2
 
 and rlk
 
2
 
/2itk2/2
Mice. To evaluate the roles of Tec family kinases in T cell
developmental processes, we examined populations of thy-
mocytes from mice deficient in Rlk, Itk, or both Tec family
kinases. Staining with anti-CD4 and -CD8 indicated that
rlk2/2 mice have apparently normal thymocyte populations,
whereas itk2/2 mice have mildly decreased thymic cellular-
ity (Table I; reference 8). In particular, there are decreased
numbers of CD41 single-positive (SP) mature cells with in-
creased numbers of CD81 SP mature cells in itk2/2 mice,
so that an altered CD4/CD8 ratio is observed (Fig. 1). Sur-
prisingly, despite their more severe defects in TCR-induced
responses in mature T cells, rlk2/2itk2/2 mice exhibit in-
creased thymic cellularity relative to itk2/2 mice. However,
rlk2/2itk2/2 thymocytes still have decreased CD4/CD8 ra-
tios similar to that observed in itk2/2 mice. Thus, although
they exhibit decreased numbers of CD41 cells, both itk2/2
and rlk2/2itk2/2 mice have increased total numbers of
CD81 SP cells compared with WT animals.
To further examine parameters of thymic development,
we examined other markers of T cell development (Fig. 1).
Whereas TCR levels on DP thymocytes were similar to
those of WT cells, both itk2/2 and rlk2/2itk2/2 mice ex-
hibited decreased TCR expression on mature cells. None-
theless, these SP cells appear mature, as indicated by low
levels of expression of human serum albumin (HSA; data not
shown). More notably, expression of the cell surface marker
CD5, which correlates with strength of TCR engagement
(9), was decreased severalfold in itk2/2 and rlk2/2itk2/2 mice.
This difference was observed in both SP and CD41CD81
DP cell populations but was most pronounced in the DP
cells, a population first undergoing engagement of the TCR.
The decreased CD5 expression parallels the observed decrease
in responsiveness to TCR stimulation in mature cell popu-
lations, arguing that thymocytes as well as peripheral cells
have decreased intensity of signaling through the TCR.
Decreased Positive Selection. The altered patterns of ma-
ture cell populations combined with the increased numbers
of mature T cells in rlk2/2itk2/2 compared with the itk2/2
animals suggested that processes of T cell development may
be distinct in mice deficient in these kinases. To examine
processes of thymic selection, we interbred rlk2/2itk2/2 an-
imals with transgenic mice expressing TCRs directed
against either the male-specific antigen HY (HY; reference
10) or a peptide from pigeon cytochrome c (AND; refer-
ence 11). Expression of these transgenes allows examina-
Table I. Thymocyte Cell Populations
Genotype n No. cells CD42CD82 CD41CD81 SP CD41 SP CD81 CD4/CD8
3106
WT 9 136 6 23 6.8 6 3.5 113 6 6.5 10.8 6 2.8 4.9 6 1.5 2.2
5.0 6 2.6% 83.5 6 4.8% 8.0 6 2.1% 3.6 6 1.1%
rlk2/2 6 151 6 35 8.7 6 4.8 125 6 5.1 12.2 6 1.8 4.4 6 1.9 2.8
5.8 6 3.2% 83.5 6 3.4% 8.1 6 1.2% 2.9 6 1.3%
itk2/2 8 97 6 23 5.6 6 3.3 76 6 3.8 6.4 6 1.4 7.9 6 1.5 0.8
5.8 6 3.4% 79.0 6 3.9% 6.6 6 1.4% 8.2 6 1.5%
rlk2/2itk2/2 8 119 6 49 7.1 6 4.2 89 6 7.0 10.9 6 1.9 11.5 6 2.9 0.95
6.0 6 3.5% 75.0 6 5.9% 9.2 6 1.6% 9.7 6 2.5%
Upper line for each genotype indicates absolute cell numbers 6 SD. Lower line indicates percentage of thymocytes in each compartment.
990 Mutation of Tec Family Kinases Alters Thymic Selection
tion of positive selection processes in the CD8 and the
CD4 lineages, respectively. Furthermore, the HY model
allows evaluation of both positive and negative selection.
Thymocytes bearing the AND TCR transgene are posi-
tively selected in the I-Ab background, showing large num-
bers of CD41 cells that express the Va11 TCR chain (11).
In WT AND1 mice, virtually all mature SP cells are CD41
and express Va11. rlk2/2AND1 mice exhibited varying
degrees of subtle defects in this selection process, as indi-
cated by slight reductions in thymic cellularity and absolute
numbers of Va11 CD41 SP cells (Fig. 2 and Table II). De-
ficiency of Itk, however, clearly decreased positive selec-
tion, with a marked reduction of Va11 CD4 SP cells se-
lected and increased numbers of double-negative and
Figure 1. Thymic development of Tec family kinase–deficient mice. Left: thymocytes stained with anti-CD4 and anti-CD8 from WT, rlk2/2, itk2/2,
and rlk2/2itk2/2 mice. Center: histogram of TCR levels from mutant mice (dark lines), overlaid on WT TCR levels (solid gray) for DP and SP CD41 and
CD81 cells. Right: histogram of CD5 levels from mutant mice (dark lines), overlaid on WT CD5 levels (solid gray) for DP and SP CD41 and CD81 cells.
Figure 2. Altered positive selection in itk2/2 and rlk2/2
itk2/2 mice expressing the AND TCR transgene. Thymic
profiles stained with anti-CD4 and anti-CD8 from two
different experiments (Exp 1 and Exp 2) to show the range
of selection in rlk2/2 animals. Experiment 2 also shows
anti-CD4 and CD8 plots gated on Va111 cells.
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immature CD8 precursor cells (Fig. 2 and Table II) (8).
Similarly, we observed a more severe decrease in positive
selection with greater reductions of CD41 cells in mice de-
ficient in both Rlk and Itk. Thus, positive selection in the
CD4 lineage with this TCR is most severely impaired in
the rlk2/2itk2/2 mice.
As both itk2/2 and rlk2/2itk2/2 mice have decreased
CD4/CD8 ratios compared with WT mice, we wished to
also examine a class I–restricted transgene. HY transgenic
mice express a class I–restricted TCR directed against the
male-specific antigen HY (10). In these mice, selection of
the TCR depends on the sex of the mouse. Female HY-
transgenic mice positively select the HY TCR into the
CD8 cell lineage in the H-2b background. Deficiency of
Rlk again had minimal effects on positive selection, as sug-
gested by the slight decreases in thymic cellularity (Table
III). As with the class II–restricted AND transgene, Itk-
deficient animals show clear decreases in positive selection
of the HY transgene (Fig. 3; reference 8). However, posi-
tive selection was even more severely affected by lack of
both kinases. Staining of both thymocytes and mature T
cells from the HY1 females with the T3.70 antibody di-
rected against the clonotypic HY TCR a chain confirmed
that positive selection was most severely decreased in the dou-
ble knockouts, even more significantly than in itk2/2rlk1/2
heterozygous mice (Fig. 3 B).
Altered Negative Selection: A Switch to Positive Selection in
rlk2/2itk2/2 Mice. Because the HY antigen is a male-spe-
cific antigen encoded by the Y chromosome, male mice
expressing the HY transgene can be used to evaluate nega-
tive selection. The HY TCR transgene is expressed early in
thymic development. Thus, in WT male HY1 mice, de-
velopment of self-reactive cells is arrested so that there are
minimal DP cells, and thymic cellularity is reduced z10-
fold (10). In this system, negative selection was not affected
by the lack of Rlk. Although it has been previously re-
ported that negative selection is not significantly impaired
by deficiency of Itk (8), we observed varying degrees of de-
fects in negative selection in itk2/2 animals (Fig. 4 A).
However, we observed marked effects on negative selec-
tion resulting from deficiency of both kinases, with a signif-
icant increase in DP and CD81 SP cells in rlk2/2itk2/2
mice (Fig. 4 A).
This defect in negative selection in rlk2/2itk2/2 animals
was further confirmed by the cellularity of the thymi from
these animals; thymic cellularity of rlk2/2itk2/2 HY1
males was increased about threefold relative to WT HY1
males (Table III). Not only was negative selection reduced
Table II. Altered Selection in AND TCR Transgenics
WT rlk2/2 itk2/2 rlk2/2itk2/2
Expt. 1 203 163 95.5 113
Expt. 2 300 200 100, 60 65
Total thymocyte numbers 3106. Cell numbers are representative of
three to five experiments. Expt., experiment.
Table III. Altered Selection in HY TCR Transgenics
HY females
WT rlk2/2 itk2/2 rlk2/2itk2/2
Expt. 1 122 110 45 38
Expt. 2 191 110 94 73
HY males
WT rlk2/2 itk2/2 rlk2/2itk2/2
Expt. 1 10 10 16 30
Expt. 2 7.6 7.6 11 26
Total thymocyte numbers 3106. Cell numbers are representative of
three to five experiments. Expt., experiment.
Figure 3. Altered positive selection in female itk2/2 and rlk2/2itk2/2
mice expressing the HY TCR transgene. (a) Profiles of thymocytes
stained with anti-CD4 and anti-CD8. (b) Cells were gated on SP CD8
cells and then examined for T3.70 (anticlonotypic TCR antibody) posi-
tive cells.
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Figure 4. Altered negative selection in male itk2/2 and rlk2/2itk2/2 mice expressing the HY TCR transgene. (a) Thymic profiles stained with anti-
CD4 and anti-CD8. (b) Profiles of cells (separate experiment from a) stained with anti-CD4, anti-CD8, and T3.70 (anticlonotypic TCR antibody). First
column (from left): thymocytes were gated on T3.701 cells and then examined for CD4 and CD8 expression. Second column: CD81 SP cells examined
for T3.70 expression. Numbers indicate percentage of total thymocytes. Third column: splenocytes were gated on T3.701 cells and then examined for
CD8 levels. Histograms from mutant mice are overlaid on a WT HY1 male (solid gray) for comparison. Numbers above line indicate the percentage of
T3.701 cells expressing CD8. Numbers below line indicate mean fluorescence intensity. Fourth and fifth columns: LN cells gated and analyzed as
above. LNs are from a separate experiment. (c) CD8 histograms of splenocytes from WT HY1 female and male and rlk2/2itk2/2 HY1 male. (continues)
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in rlk2/2itk2/2 HY1 male mice, but we observed a relative
increase in CD81 SP cells, in particular of those expressing
the HY TCR (Fig. 4 B). In WT male HY1 mice, the
T3.70 cells that mature and populate the periphery express
decreased levels of the coreceptor CD8 and are function-
ally anergic. Unlike WT male HY mice, HY1 rlk2/2itk2/2
males have increased numbers of T3.701 cells in the pe-
riphery that express near normal levels of CD8 (Fig. 4, B
and C). The profile of these peripheral cells is therefore
remarkably similar to that observed in WT HY females
that have undergone positive selection (Fig. 4 C). Together,
these results are suggestive of a switch from negative selec-
tion to positive selection in the double-knockout mice.
Furthermore, these peripheral cells in HY1 rlk2/2itk2/2
males can respond to the HY antigen, as demonstrated by
proliferation assays using the HY peptide and APCs as
stimuli (Fig. 4 D), although they respond very poorly,
consistent with the abnormal responses in TCR-mediated
signaling seen in rlk2/2itk2/2 mature T cells. These results
suggest that the increased thymic cellularity in rlk2/2itk2/2
mice, compared with itk2/2 mice, could result from de-
fects in negative selection and that reduction in TCR sig-
naling can lead to a paradoxical increase in thymic cellu-
larity.
Decreased In Vitro Deletion of Thymocytes. To further ex-
amine negative selection, we used an in vitro model of
thymocyte deletion induced by plate-bound anti-CD3 and
-CD28 antibodies, a strong stimulus that has been shown
to drive apoptosis in the majority of DP thymocytes in cul-
ture (12). As shown in Fig. 5 A, cell death induced by anti-
CD3 plus anti-CD28 was decreased in rlk2/2itk2/2 cells,
consistent with our in vivo observations using the HY
model.
Surprisingly, treatment of either the itk2/2 and rlk2/2itk2/2
thymocytes with anti-CD3 and anti-CD28 gave rise to al-
tered cell populations. Engagement of the TCR in WT or
Rlk-deficient cells caused a decrease of DP cells concurrent
with engagement of the TCR. However, in both the itk2/2
and double-knockout genotypes, we observed a shift in cell
populations so that there was a marked increase in the
numbers of CD41 cells present in rlk2/2itk2/2 mice (Fig. 5 B).
To determine whether this CD41 population resulted
from proliferation of mature CD41 SP cells, we enriched
for CD41CD81 DP cell by panning with anti-CD8 and
performed similar experiments. In this cell population, we
again saw decreased cell death in the rlk2/2itk2/2 cells, as
apparent both by the percentage PI1 cells and the absolute
number of viable DP cells (Fig. 5 C). Intermediate defects
were observed in cells from rlk2/2 and itk2/2 mice. In con-
trast, neither dexamethasone- (data not shown) nor anti-
Fas–mediated cell death were reduced in thymocytes from
the Tec-deficient mice, arguing that the decreased cell
death results specifically from defects in TCR/CD28-
mediated responses. Furthermore, we also observed a strik-
ing increase in absolute numbers of CD41 cells present af-
ter 24-h stimulation with anti-CD3 and anti-CD28 (Fig. 5,
C and D). For itk2/2 cells, CD4 levels remained relatively
low, whereas in the rlk2/2itk2/2 cells, CD4 levels were in-
creased. This population of CD4 cells exhibited higher lev-
els of a/b TCR than DP cells but lower than CD4 SP cells
from ex vivo thymi (Fig. 5 E). Similarly, these CD4 cells
had not fully downregulated the immature cell marker
HSA but were lower in HSA than DP cells (data not
shown). The intermediate levels of TCR, CD4, and HSA
are suggestive of a CD41CD8lo stage previously described
as a precursor population to both CD41 and CD81 SP cells
(13) and is reminiscent of that seen in an in vitro assay for
thymocyte differentiation (14). The phenotype of these
CD41 cells is therefore suggestive of progression of DP to
an intermediate pre-SP stage rather than proliferation of an
already mature SP CD41 population. The novel appear-
ance of this CD4 cell population was particularly pro-
nounced in the double knockouts, again suggesting a
switch from deletion to a developmental pathway. Thus, a
signal that would normally induce death appears to induce
survival and differentiation of rlk2/2itk2/2 thymocytes.
Biochemical Defects in rlk2/2itk2/2 Mice. To evaluate the
nature of the defects in the rlk2/2itk2/2 thymocytes, we
examined signaling events downstream of TCR engage-
ment. Although modest delays in tyrosine phosphorylation
of proteins can be observed after anti-CD3 stimulation, to-
tal phosphotyrosine patterns were grossly normal (Fig. 6
A). We have previously reported that tyrosine phosphory-
lation of TCR z chain and ZAP-70 was normal in CD3-
stimulated mature cells, indicating normal early tyrosine
(continued) Histograms from mutant mice are overlaid on a WT non-HY
female (solid gray) for comparison of CD8 levels. (d) Proliferation of sple-
nocytes from HY1 transgenic mice. Top: proliferation of WT HY1 sple-
nocytes incubated with varying ratios of irradiated WT APCs plus HY
peptide. Bottom: proliferation of rlk2/2itk2/2HY1 splenocytes incubated
with varying ratios of irradiated WT APCs plus HY peptide. Different
scales are used in the top and bottom panels due to the poor proliferative
responses of rlk2/2itk2/2 T lymphocytes. Note that WT female HY1
splenocytes proliferate to the HY antigen in a dose-responsive fashion. In
contrast, rlk2/2itk2/2 HY1 male splenocytes proliferate to the HY antigen
(whereas the nonselected female cells fail to proliferate).
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Figure 5. Abnormal responses to death-inducing signals in itk2/2 and rlk2/2itk2/2 thymocytes. (a) Altered responses to plate-bound anti-CD3 and
CD28. Isolated cells from total thymi were plated on anti-CD3 and CD28 for 16–24 h, stained for CD4 and CD8, and analyzed in the presence of PI. (b)
CD4 versus CD8 cell analyses of total thymocytes treated as in a. (c) Cells viability (percentage PI1), total live DP cells, and total live CD41 cells from
enriched DP cell populations treated with plate-bound anti-CD3 and CD28 or anti-Fas for 24 h (* indicates live cell numbers ,0.1 on these graphs). (d)
Flow cytometry analyses of cells stained for CD4 and CD8 derived from enriched DP cells treated for 24 h. (e) Intermediate low TCR levels on CD41
SP cells from rlk2/2itk2/2 thymocytes after treatment with plate-bound anti-CD3 and CD28. TCR levels of CD41 cells (hatched line) overlaid on TCR
levels of DP cells (solid gray) and CD4 SP cells from ex vivo thymi (dark line).
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phosphorylation events (7). Similarly, tyrosine phosphory-
lation of z chain and Zap-70 were grossly intact in thy-
mocytes activated with anti-CD3e (data not shown).
In contrast to normal activation of immediate early TCR
signaling events, we observed clear alterations in Ca21 mo-
bilization in response to anti-CD3 stimulation, with graded
defects in the itk2/2 and rlk2/2itk2/2 cells (Fig. 6 B). In pe-
ripheral T cells from itk2/2 and rlk2/2itk2/2 mice, we have
observed defects in both the initial peak and prolonged
phase of Ca21 mobilization (7, 15). However, in thy-
mocytes, alterations in Ca21 mobilization were limited to
the late phase of Ca21 influx. Inclusion of EGTA in the
media resulted in nearly identical Ca21 profiles from all
genotypes, confirming that the defects were restricted to
capacitive Ca21 influx from external sources. Incubation
with thapsigargan, an inhibitor of the endoplasmic reticular
Ca21 ATPase (16), led to normal Ca21 influx, demonstrat-
ing that store-operated Ca21 mobilization was similar in all
mice (data not shown) and suggesting that the defect lay in
the regulation of Ca21 mobilization. In lymphocytes, Ca21
mobilization is controlled by the activity of PLC-g (17,
18), which cleaves phosphoinositide 4,5-bisphosphate to
diacylglycerol, which activates protein kinase C family
members, and inositol triphosphate, which binds to recep-
tors on intracellular organelles, inducing the release of in-
tracellular Ca21 stores and the subsequent activation of
capacitive Ca21 influx from extracellular sources (19). Con-
sistent with the defective Ca21 responses in rlk2/2itk2/2
thymocytes, we also observed mild defects in tyrosine phos-
phorylation of PLC-g1 after stimulation with antibodies to
CD3e (Fig. 6 C).
Recently, Tec family kinases have been implicated as
part of complexes nucleated by the adaptor molecules
linker of activated T cells (LAT) and Src homology 2 do-
main–containing lymphocyte protein of 76 kD (SLP-76)
that are required for activation of PLC-g and Ca21 mobili-
zation (Fig. 7 A; references 20–24). To examine how defi-
ciency of Tec kinases affects other components of this sig-
naling complex, we looked at the tyrosine phosphorylation
of LAT and other GRB-2–associated molecules including
SLP-76 and Cbl (25, 26). Again, we observed normal pat-
terns of tyrosine phosphorylation with only modest delays
in tyrosine phosphorylation of GRB-2–associated proteins
(Fig. 7, B and C). Similarly, tyrosine phosphorylation of
Vav, another molecule recruited into this complex (27),
was also intact. These data suggest that although Tec ki-
nases contribute to these complexes, phosphorylation and
assembly of components of these complexes can occur in-
dependently of Tec family kinases.
The LAT–GRB-2/Gads–SLP-76–PLC-g and Tec fam-
ily kinase complexes are thought to be critical determinants
of both Ca21 mobilization and activation of the MAP ki-
nases (MAPKs) ERK 1 and 2 (7, 21, 23, 24). Because ERK
signaling has been shown to influence CD4 and CD8 lin-
eage commitment (28, 29) and both itk2/2 and rlk2/2itk2/2
mice exhibit altered CD4/CD8 ratios, we examined
whether defects in ERK activation existed in thymocytes
from these mice. We observed a reproducible decrease in
Figure 6. Altered Ca21 mobilization in response to
anti-CD3 stimulation in itk2/2 and rlk2/2itk2/2 cells.
(a) Normal patterns of tyrosine phosphorylation after
anti-CD3 stimulation of rlk2/2itk2/2 thymocytes. Cells
were stimulated with plate-bound anti-CD3 for indi-
cated times and then lysed and analyzed for phosphoty-
rosine by immunoblotting. (b) itk2/2 and rlk2/2itk2/2
thymocytes exhibit decreased Ca21 mobilization in re-
sponse to TCR stimulation. First arrow, addition of bi-
otinylated anti-CD3; second arrow, addition of strepta-
vidin. Cells were analyzed in the presence (left) or
absence (right) of EGTA. (c) Altered PLC-g phos-
phorylation in rlk2/2itk2/2 thymocytes in response to
TCR stimulation. Lysates from cells stimulated as
above were immunoprecipitated with anti–PLC-g and
immunoblotted with antiphosphotyrosine.
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ERK activation in response to anti-CD3 stimulation in
both itk2/2 and rlk2/2itk2/2 thymocytes (Fig. 7 D), consis-
tent with the decreased number of CD4 SP cells present in
these mice. In contrast, activation of p38, a MAPK shown
to influence negative selection (3), appears relatively nor-
mal in thymocytes from these mice (Fig. 7 D), suggesting
that activation of this MAPK is independent of PLC-g ac-
tivation.
Discussion
Using mice with targeted mutations of Rlk, Itk, or both
T cell–specific Tec kinases, we demonstrate here that mod-
ification of T cell signaling through mutation of these ki-
nases leads to altered thymic development. Specifically, we
provide evidence that mutation of the Tec kinases in T
cells decreases both Ca21 mobilization and MAPK activa-
tion in thymocytes and leads to switches from positive se-
lection to death by neglect and from negative selection to
positive selection. These results are consistent with a model
in which developmental decisions in the thymus are influ-
enced by diminished signaling through the TCR. Thus,
thymocytes that would normally see a weak, positively se-
lecting stimulus register this as a weaker signal in itk2/2 and
rlk2/2itk2/2 mice and convert positive selection to death by
neglect. Likewise, rlk2/2itk2/2 cells interpret a strong stim-
ulus normally leading to cell death as a weaker signal lead-
ing to positive selection. These results correlate with ex-
pression levels of CD5 in DP cells from the mutant mice,
expression of which has been found to parallel the strength
of TCR engagement (9).
It is not clear whether distinct signals mediate positive
and negative selection in the thymus. For example, alter-
ation of the MAPK pathway by expression of dominant-
negative mutants of Ras and MEKK can alter positive se-
lection with minimal effects on negative selection, whereas
interference with p38 or Jun NH2-terminal kinase activa-
tion inhibits negative selection (2, 3). One interpretation of
our data is that Rlk contributes a specific signal required for
negative selection, either downstream of the TCR or from
Figure 7. Analyses of proteins in Ca21–MAPK complex: normal tyrosine phosphorylation of components of Ca21 complex, but decreased activation
of ERKs. (a) Complex of LAT-associated proteins required for normal Ca21 mobilization and activation of ERKs. (b) Normal patterns of tyrosine-phos-
phorylated proteins associated with GRB-2, including LAT (36–38 kD), SLP-76 (76 kD), and Cbl (120 kD) after anti-CD3 stimulation. Cells were stim-
ulated for indicated times on plate-bound anti-CD3e and lysed, and clarified lysates were incubated with GRB-2–GST on glutathione beads. Affinity-
purified proteins were immunoblotted with antiphosphotyrosine. (c) Normal tyrosine phosphorylation of LAT, Cbl, and Vav after anti-CD3 stimulation.
Cells were stimulated for indicated times, and immunoprecipitated proteins were immunoblotted with antiphosphotyrosine. (d) Altered activation of the
MAPKs ERK 1 and 2. Cells were stimulated with anti-CD3, and lysates were analyzed for dually phosphorylated active ERK 1 and 2 and total levels of
ERK 2. Bottom panel, lysates were analyzed with antiactive (phospho)-p38.
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coreceptors such as CD28. Although we have not seen ev-
idence of this in the rlk2/2 mice, either in HY male mice
or in an in vitro model of deletion using anti-CD3 and
CD28 antibodies, it is also possible that this phenotype may
only be revealed in the context of Itk deficiency.
Alternatively, regulation of positive and negative selec-
tion may not require distinct signals but rather the same
signals operating at different intensities (1). Negative selec-
tion may therefore involve the same biochemical interme-
diates as positive selection but require a stronger or more
prolonged signal through the TCR and may be less sensi-
tive to small perturbations in signaling. By this model,
slight defects in TCR signaling could minimally affect pos-
itive selection while not impairing negative selection.
Moderate defects in TCR signaling, as in the itk2/2 mice,
could alter positive selection in the AND and HY models
but have a less severe effect on negative selection. The
more profoundly impaired TCR signaling in rlk2/2itk2/2
double knockouts, as demonstrated by their defect in Ca21
mobilization (Fig. 6), may not only more severely affect
positive selection but also impact negative selection. Similar
phenotypes are observed in mice with mutations of the z
chain of the TCR (30, 31). The graded nature of the de-
fects we observe in positive and negative selection suggests
that these processes may be part of a continuum, consistent
with a quantitative view of thymic selection processes. It
should be noted, however, that these quantitative differ-
ences may be translated into differential activation of
downstream molecules, perhaps accounting for data sup-
porting both models of selection.
Although we cannot rule out other effects resulting from
elimination of both Rlk and Itk, particularly effects on
other signaling pathways, our data suggests that diminished
TCR signaling can in fact lead to a paradoxical increase in
thymic cellularity in rlk2/2itk2/2 mice compared with itk2/2
mice due to decreased negative selection. This increased
cellularity has additional implications for the relative num-
bers of cells undergoing negative selection in the thymus.
Estimates of cells undergoing negative selection have varied
widely depending on the system used to examine this ques-
tion (32–36). Our results suggest that defects in this process
can significantly influence cell number and lead to in-
creased thymic cellularity.
The development of cells that would normally be de-
leted, as in the rlk2/2itk2/2 HY1 male mice, also suggests
that reduction of signal may lead to the development of au-
toreactive cells, a process that may contribute to the devel-
opment of autoimmunity in immunocompromised hosts.
Nonetheless, the potentially self-reactive cells that develop
in young male rlk2/2itk2/2HY1 mice respond poorly to self
HY antigen and do not show evidence of activation mark-
ers, including CD69 and CD25 (data not shown), consis-
tent with the cellular and biochemical defects we observe in
mature cells. Indeed, in order for these cells to proliferate in
vitro, addition of exogenous peptide was required. This de-
creased reactivity may account for a lack of obvious signs of
autoimmunity in these animals. Whether the activity of
these escaped self-reactive cells may be altered under certain
conditions, leading to an autoimmune response, remains
an interesting question for future exploration. Notably, a
high percentage of T cells from itk2/2 and, even more so,
rlk2/2itk2/2 mice express memory cell markers (Schaeffer,
E.M., C. Broussard, and P.L. Schwartzberg, unpublished
observations). It is interesting to speculate that these mem-
ory cells might result from tonic stimulation of TCRs that
recognize self-antigens.
Biochemically, the defects we observe are consistent
with an emerging picture of Tec family kinases as a compo-
nent of a signaling complex including LAT and SLP-76
that is required for full PLC-g activation, Ca21 mobiliza-
tion, and ERK activation (7, 15, 20, 22). Both SLP-76 and
LAT have recently been shown to bind to Itk in an induc-
ible fashion, thereby providing a mechanism for recruiting
Tec family kinases into this complex (20, 22). In peripheral
cells, the Tec kinases have been implicated in the phos-
phorylation and activation of PLC-g. Our biochemical
data suggests that, in thymocytes, Tec family kinases are
also required for full Ca21 mobilization and MAPK activa-
tion downstream of PLC-g (7, 15, 37–39). However, the
relatively normal tyrosine phosphorylation of LAT and the
other GRB-2–associated molecules including SLP-76 and
Cbl suggest that, unlike the more proximal components,
the Tec kinases are probably not required to initiate forma-
tion of this complex. It is notable that we have observed
mild kinetic delays in tyrosine phosphorylation of compo-
nents of this complex. Thus, we cannot rule out the possi-
bility that Tec kinases either may contribute to these phos-
phorylation events or alternatively may be important for
the integrity of this Src homology 2–mediated complex.
The recent observation that Rlk can phosphorylate SLP-76
supports this notion (40).
Mutation of these kinases, therefore, gives rise to bio-
chemical defects similar to but less severe than that seen in
LAT- or SLP-76–deficient cells (21, 23). Thus, mutation of
the Tec kinases, unlike that of the more proximal tyrosine
kinases or the more proximal components of the Ca21
complex, does not eliminate downstream signaling nor pre-
vent T cell development but merely changes the character
or duration of the signal, leading to altered thresholds for
selection. This altered selection in response to signaling de-
fects is reminiscent of that observed with altered peptide
ligands (APLs) with reduced TCR activation (41–43).
Thus, just as activation of a TCR by APLs permits develop-
ment of thymocytes (44), mutation of the Tec kinases can
permit development of cells that might normally be deleted.
Proper activation of the Tec kinases may therefore be criti-
cal for helping determine selection processes in the thymus.
The defects we observe in Ca21 mobilization are consis-
tent with a role for Tec kinases in regulating capacitive
Ca21 entry (45). Inclusion of EGTA generates Ca21 mobi-
lization profiles that are not significantly different than
those of WT cells, suggesting that other molecules contrib-
ute to the initial activation of PLC-g, particularly in thy-
mocytes. These results are similar to those observed in B
lymphocytes from XLA patients where altered PLC-g acti-
vation lead to defects that are most pronounced in the late
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phases of capacitive Ca21 entry (37). Although mutation of
rlk itself does not lead to significant phenotypes, mutation
of this gene substantially worsens the itk2/2 phenotype (7),
and overexpression of Rlk/Txk can partially compensate
for the lack of Itk (46, 47), suggesting potential redundancy
between these two Tec kinases in T cells. Thus, as in Btk-
deficient B lymphocytes, the Tec kinases Itk and Rlk to-
gether appear essential for regulating the full activation of
PLC-g–mediated pathways required for capacitive Ca21
entry in thymocytes.
In lymphocytes, data suggest that PLC-g also contributes
to the activation of ERKs in response to antigen receptor
stimulation by a protein kinase C (PKC)-mediated activa-
tion of Ras and Raf, in addition to the well established
GRB-2–son of sevenless (SOS) pathway (48, 49). Despite
the relative integrity of GRB-2–associated proteins in itk2/2
and rlk2/2itk2/2 cells, we observe a defect in ERK activa-
tion. Thus, this defective ERK activation may result from
defects in a PLC–PKC- dependent pathway. It is notable
that we do not observe defect in activation of p38 in these
cells, despite defects in negative selection. Thus, p38 acti-
vation may be independent of PLC-g activation and prob-
ably does not contribute to the defects in negative selection
observed in rlk2/2itk2/2 mice.
Our observed defect in ERK activation is particularly in-
triguing given the decreased CD4/CD8 ratio observed in
itk2/2 and rlk2/2itk2/2 mice. The factors that affect lineage
decision commitment between CD4 and CD8 cells remain
controversial (50, 51). Again, at least one model suggests
that alterations in signaling intensity can help determine
this lineage determination, with development of CD41
cells requiring a stronger signal. However, several specific
molecules have also been implicated in the regulation of
this cell fate decision, including Notch (52), Lck (53, 54),
and the MAPKs ERK 1 and 2 (28, 29). It is possible that
these molecules may contribute to lineage determination
by influencing signal intensity or duration or by permitting
survival of cells that would normally die due to low signal-
ing. Our data is consistent with that from studies by Bomm-
hardt et al (28) and Sharp et al. (29), who demonstrate that
decreased activation of ERKs can alter the lineage decision
between CD41 and CD81 cells. As both itk2/2 and the
rlk2/2itk2/2 cells exhibit decreased activation of ERK 1
and 2 as a consequence of their defects in signaling down-
stream from the TCR (Fig. 7), the decreased CD41 cell
number and relative increase in CD81 cells in both these
strains is consistent with previous results using either
MEKK inhibitors or a hypersensitive mutant of ERK 2.
These data suggest that diminished signaling from the TCR
can influence lineage commitment, perhaps by affecting ac-
tivation of specific downstream molecules, and directly im-
plicate Tec kinases as part of the signaling pathways influ-
encing this decision.
These studies provide further insight into the biochemi-
cal intermediates that influence cell fate decisions in the
thymus and contribute to the development of the T cell
repertoire. Specifically, these data provide evidence that the
Tec kinases contribute to setting thresholds required for
thymic selection and lineage commitment by controlling
activation of downstream signaling molecules. Thus, proper
activation of Tec family kinases may be critical for thy-
mocyte selection decisions. In particular, the switch from
negative selection to positive selection and the increased
thymic cellularity in the rlk2/2itk2/2 animals highlights the
complex nature of thymic selection, where reduction of
TCR signaling may not merely decrease selection but may
alter selection and lineage decisions. How defects in these
signaling pathways influence these developmental selection
decisions may be further delineated through the generation
of knockout mice deficient in all three Tec kinases ex-
pressed in T cells and the use of different TCR-transgenic
mice with varying affinities and avidities of TCR engage-
ment.
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